4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-042169
Chief Operating Officer sold 10,435 shares at an average $13.06 ($136,263)
- Chief Operating Officer acquired 10,435 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Capponi Vincent Chief Operating Officer | 2018-08-02 | Option exercise | +2,835 | $3.45 | $9,781 | 335,603 | D: show line 1 in the form |
| Capponi Vincent Chief Operating Officer | 2018-08-02 | Sale | −2,835 | $13.00 | $36,855 | 332,768 | D: show line 2 in the form |
| Capponi Vincent Chief Operating Officer | 2018-08-03 | Option exercise | +7,600 | $3.45 | $26,220 | 340,368 | D: show line 3 in the form |
| Capponi Vincent Chief Operating Officer | 2018-08-03 | Sale | −7,600 | $13.08 | $99,408 | 332,768 | D: show line 4 in the form |
| Open-market sales · 10,435 sh · avg $13.06 · $136,263 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Capponi Vincent Chief Operating Officer | 2018-08-02 | Option exercise · Stock Option (right to buy) | −2,835 | 58,465 | D: show line 5 in the form | |||||
| Capponi Vincent Chief Operating Officer | 2018-08-03 | Option exercise · Stock Option (right to buy) | −7,600 | 50,865 | D: show line 6 in the form |
Loading xslF345X03/tv500216_4.xml…